Pan Yunzhi, Shu Xiong, Sun Lichao, Yu Long, Sun Lixin, Yang Zhihua, Ran Yuliang
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang, Beijing 100021, P.R. China.
Int J Oncol. 2017 Jun;50(6):1965-1976. doi: 10.3892/ijo.2017.3965. Epub 2017 Apr 19.
Cancer stem cells (CSCs) are undifferentiated cancer cells with a high tumorigenic activity, the ability to undergo self-renewal, and a multilineage differentiation potential. Clinical evidence suggests that CSCs in a tumor mass are the cellular determinants to promote cancer invasion and metastasis. MicroRNAs (miRNAs) have emerged as important modulators of cancer stem cell characteristics. Unveiling the candidate miRNAs that regulate CSCs may provide novel therapeutic targets against cancer. We analyzed the miRNA expression profiles regulating the cancer stem-like cell characteristics in gastric cancer. Gastric cancer stem cells (GCSCs) were sorted using the stem cell marker CD44 by fluorescence-activated cell sorting. Functional studies revealed that CD44(+) cells formed more sphere colonies and showed higher invasiveness than CD44(-) cells. miRNA microarray analysis revealed that miR‑196a‑5p was significantly upregulated in CD44(+) cells than CD44(-) cells. Suppression of miR‑196a‑5p led to decreased colony formation and invasion of GCSCs. miR‑196a‑5p decreased the expression of Smad4 by targeting 3'-UTR of the mRNA. The expression of Smad4 in gastric cancer tissues was correlated with differentiation state of tumors, TNM stage and depth of invasion. The stimulation of epithelial-mesenchymal transition (EMT) by miR‑196a‑5p in cancer stem-like cells was abolished by overexpression of Smad4. Collectively, these data demonstrate that miR‑196a‑5p has a key role in EMT and invasion by targeting Smad4 in GCSCs. miR‑196a‑5p may serve as a potential target for gastric cancer therapy.
癌症干细胞(CSCs)是具有高致瘤活性、自我更新能力和多谱系分化潜能的未分化癌细胞。临床证据表明,肿瘤块中的癌症干细胞是促进癌症侵袭和转移的细胞决定因素。微小RNA(miRNAs)已成为癌症干细胞特征的重要调节因子。揭示调控癌症干细胞的候选微小RNA可能为癌症提供新的治疗靶点。我们分析了调控胃癌中癌症干细胞样细胞特征的微小RNA表达谱。通过荧光激活细胞分选使用干细胞标志物CD44对胃癌干细胞(GCSCs)进行分选。功能研究表明,CD44(+)细胞比CD44(-)细胞形成更多的球状体集落并表现出更高的侵袭性。微小RNA微阵列分析显示,与CD44(-)细胞相比,miR‑196a‑5p在CD44(+)细胞中显著上调。抑制miR‑196a‑5p导致GCSCs的集落形成和侵袭减少。miR‑196a‑5p通过靶向mRNA的3'-UTR降低Smad4的表达。胃癌组织中Smad4的表达与肿瘤的分化状态、TNM分期和侵袭深度相关。Smad4的过表达消除了miR‑196a‑5p在癌症干细胞样细胞中对上皮-间质转化(EMT)的刺激作用。总体而言,这些数据表明miR‑196a‑5p通过靶向GCSCs中的Smad4在EMT和侵袭中起关键作用。miR‑196a‑5p可能作为胃癌治疗的潜在靶点。